In addition, the distance between blood vessels and CD8+ cells was not significantly affected by TKI treatment (Supplementary Fig. S8E and S8F), with lymphocytes located at 10 to 50 μm from the closest blood vessel, similar to control-treated bone tumors. This evidence concerns the gene CD8A and bone neoplasm.